Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.030 Biomarker disease BEFREE The <i>N</i>-hexane extract of the marine sponge <i>Hyrtios erectus</i>, collected from North Bay, South Andaman Sea, India, showed potential antiproliferative and proapoptotic properties against a breast adenocarcinoma cell line (MCF-7).The sponge extract retarded the growth of breast carcinoma cell line MCF-7 cells in a time- and dose-dependent manner.The sponge extract induced apoptosis of breast cancer cell line MCF-7 and arrested cells in G<sub>2</sub>/M phase.The sponge extract induced downregulation of Bcl-2 protein in MCF-7 cell line and upregulation of Bax, caspase-3, and cleaved PARP. 28479725 2017
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.030 AlteredExpression disease BEFREE Gold and Silver Nanoparticles Biomimetically Synthesized Using Date Palm Pollen Extract-Induce Apoptosis and Regulate p53 and Bcl-2 Expression in Human Breast Adenocarcinoma Cells. 29552710 2018
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.030 Biomarker disease BEFREE We recently found that Rottlerin not only inhibits proliferation but also causes Bcl-2- and Beclin 1-independent autophagic death in apoptosis-resistant breast adenocarcinoma MCF-7 cells. 25661734 2015
Entrez Id: 8678
Gene Symbol: BECN1
BECN1
0.020 Biomarker disease BEFREE We recently found that Rottlerin not only inhibits proliferation but also causes Bcl-2- and Beclin 1-independent autophagic death in apoptosis-resistant breast adenocarcinoma MCF-7 cells. 25661734 2015
Entrez Id: 8678
Gene Symbol: BECN1
BECN1
0.020 Biomarker disease BEFREE AnnexinV-FITC and TUNEL positive cells seen in TOV-112D and MDA-MB-231 suggested that inhibition was via apoptosis while the presence of anti-BECLIN1 and anti-LC3B antibodies seen with MG-63 indicated autophagy. 22275115 2012
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.310 Biomarker disease BEFREE Regarding molecular factors, all driver mutations in lung adenocarcinoma had a favorable effect (EGFR, HR 0.53, 95%CI 0.31-0.89; ALK, HR 0.28, 95%CI 0.12-0.66; KRAS, HR 0.65, 95%CI 0.47-0.92), triple negative status predicted poor prognosis in breast adenocarcinoma (HR 2.04, 95%CI 1.13-3.69), while no effect of BRAF/NRAS mutations was demonstrated in melanoma BMs. 30989623 2019
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.310 CausalMutation disease CGI
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
0.330 GenomicAlterations disease CGI
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
0.330 GeneticVariation disease BEFREE In this case report, the hyperestrogenemia may have further increased the BrCa risk in a patient with other risk factors (BRCA-1 mutation and chromosome 9 inversion, which has been previously shown to impinge upon testicular function and intracrine balance of androgens vs. estrogens). 15154626 2004
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
0.330 Biomarker disease BEFREE We report the case of a 46-year-old woman previously treated for ductal adenocarcinoma of the breast with BRCA-1 who subsequently was diagnosed with multicentric glioblastoma multiforme (GBM) in the right temporal and right occipital lobes. 16958968 2008
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
0.330 GeneticVariation disease BEFREE The semi-quantitative PCR-based assay was used to determine the lesion frequencies produced by carboplatin in the 696-bp fragment of the 3'-region of BRCA1 gene and in the 3,426-bp fragment of the BRCA1 exon 11 of human breast adenocarcinoma MCF-7 cells. 16099593 2005
Entrez Id: 672
Gene Symbol: BRCA1
BRCA1
0.330 CausalMutation disease CGI
Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
0.300 GenomicAlterations disease CGI
Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
0.300 CausalMutation disease CGI
Entrez Id: 83990
Gene Symbol: BRIP1
BRIP1
0.300 CausalMutation disease CGI
Entrez Id: 685
Gene Symbol: BTC
BTC
0.010 AlteredExpression disease BEFREE We found that in breast adenocarcinoma MCF7 cells overexpressing pro-BTC, hydrogen peroxide (H2O2) was a powerful stimulator of ectodomain shedding. 16676357 2006
Entrez Id: 695
Gene Symbol: BTK
BTK
0.300 CausalMutation disease CGI
Entrez Id: 767
Gene Symbol: CA8
CA8
0.010 AlteredExpression disease BEFREE Congener- and concentration-dependent antagonism of 17beta-estradiol (E2)-induced gene expression, rather than induction of ER-dependent gene expression, was observed for the MeSO(2)-PCBs on lucifierase activity in stably transfected human breast adenocarcinoma T47D cells (ER-CALUX) and vitellogenin (vtg) production in primary hepatocytes from male carp fish (Cyprinus carpio) (CARP-HEP/vtg). 12377985 2002
Entrez Id: 23705
Gene Symbol: CADM1
CADM1
0.010 AlteredExpression disease BEFREE Higher CADM1 expression correlates with improved patient survival in 2 lung and 1 breast adenocarcinoma patient cohorts and decreased metastasis. 29324443 2018
Entrez Id: 821
Gene Symbol: CANX
CANX
0.010 AlteredExpression disease BEFREE We also used RT-PCR to show that the expression of calnexin was decreased in HT-29 cells and MCF-7 human breast adenocarcinoma cells growing in suspension in poly(hydroxyethyl methacrylate)-coated wells compared to cells growing as monolayers. 9299453 1997
Entrez Id: 841
Gene Symbol: CASP8
CASP8
0.300 CausalMutation disease CGI
Entrez Id: 842
Gene Symbol: CASP9
CASP9
0.010 AlteredExpression disease BEFREE The apoptosis-induction of ICD-85 on MCF-7 cell was found to be through activation of caspase-9 which was 13 fold greater than unexposed cell. 31089358 2019
Entrez Id: 857
Gene Symbol: CAV1
CAV1
0.010 Biomarker disease BEFREE Our current findings provide for the first time in vivo evidence that caveolin-1 can indeed function as a tumor suppressor in human breast adenocarcinoma derived from MCF-7 cells rather than as a tumor promoter. 18778685 2008
Entrez Id: 8839
Gene Symbol: CCN5
CCN5
0.010 AlteredExpression disease BEFREE CCN5/WISP-2 expression in breast adenocarcinoma is associated with less frequent progression of the disease and suppresses the invasive phenotypes of tumor cells. 18794149 2008
Entrez Id: 10575
Gene Symbol: CCT4
CCT4
0.030 Biomarker disease BEFREE In addition, these compounds were evaluated for their in vitro inhibition of human cancer cell lines viz human cervical carcinoma cell line (SiHA), breast adenocarcinoma (MDA-MB-235) and human pancreas carcinoma (PANC-1) cell lines by using the SRB assay method. 29138963 2018